[1] DE VUYST E, SALMON M, EVRARD C, et al. Atopic dermatitis studies through in vitro models[J]. Front Med (Lausanne), 2017, 4:119. [2] LEUNG D Y, BOGUNIEWICZ M, HOWELL M D,et al. New insights into atopic dermatitis[J]. J Clin Invest, 2004, 113(5):651-657. [3] PARK K D, PAK S C, PARK K K.The pathogenetic effect of natural and bacterial toxins on atopic dermatitis[J]. Toxins(Basel), 2016, 9(1):E3. [4] DRUCKER A M, EYERICH K, DEBRUIN-WELLER M S, et al. Use of systemic corticosteroids for atopic dermatitis:International Eczema Council consensus statement[J]. Br J Dermatol, 2018, 178(3):768-775. [5] SHRESTHA S, MIAO R, WANG L, et al. Burden of atopic dermatitis in the United States:analysis of healthcare claims data in the commercial, medicare, and medical databases[J]. Adv Ther, 2017, 34(8):1989-2006. [6] ARIMA K, GUPTA S, GADKARI A, et al. Burden of atopic dermatitis in Japanese adults:analysis of data from the 2013 National Health and Wellness Survey[J]. J Dermatol, 2018, 45(4):390-396. [7] CHOOPANI R, MEHRBANI M, FEKRI A, et al. Treatment of atopic dermatitis from the perspective of traditional persian medicine:presentation of a novel therapeutic approach[J].J Evid Based Complement Altern Med, 2017,22(1):5-11. [8] YANG J H, LEE E, LEE B, et al. Ethanolic extracts of Artemisia apiacea hance improved atopic dermatitis-like skin lesions in vivo and suppressed TNF-alpha/IFN-gamma(-) induced proinflammatory chemokine production in vitro [J]. Nutrients, 2018, 10(7):E806. [9] 王俊霞, 杨子微, 车雅敏. 特应性皮炎小鼠模型研究进展[J]. 天津医科大学学报,2017, 23(4):383-385. [10] KIM J, LEE J, SHIN S, et al. Molecular mechanism of atopic dermatitis induction following sensitization and challenge with 2,4-dinitrochlorobenzene in mouse skin tissue[J]. Toxicol Res, 2018, 34(1):7-12. [11] HOU D D, DI Z H, QI R Q, et al. Sea buckthorn (Hippophae rhamnoides L.) oilimproves atopic dermatitis-like skin lesions via inhibition of NF-kappaB and STAT1 activation[J]. Skin Pharmacol Physiol, 2017, 30(5):268-276. [12] 莫俊銮, 周继昌, 刘小立, 等. DNCB致敏诱导BALB/c小鼠特应性皮炎模型的建立[J]. 中国热带医学,2013, 13(12):1439-1442. [13] MARSELLA R, DE BENEDETTO A. Atopic dermatitis in animals and people:anupdate and comparative review[J]. Vet Sci, 2017, 4(3):E37. [14] JANG H Y, KOO J H, LEE S M, et al. Atopic dermatitis-like skin lesions aresuppressed in fat-1 transgenic mice through the inhibition of inflammasomes[J]. Exp Mol Med, 2018,50(6):1-9. [15] SPERGEL J M, MIZOGUCHI E, BREWER J P, et al. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice[J]. JClin Invest, 1998,101(8):1614-1622. [16] 窦侠, 刘小明, 李子卓, 等. 粉尘螨诱导建立"特应性皮炎-哮喘"小鼠模型[J].中国皮肤性病学杂志, 2018, 32(3):275-280. [17] 李辉, 高强, 王翼腾. 应用小鼠建立特应性皮炎模型的研究进展[J].武警医学, 2015, 26(1):99-102. [18] YU J S, LEE C J, LEE H S, et al. Prevalence of atopic dermatitis in Korea:analysis by using national statistics[J].J Korean Med Sci, 2012, 27(6):681-685. [19] SYBILSKI A J, ZALEWSKA M, FURMANCZYK K, et al. The prevalence of sensitization to inhalant allergens in children with atopic dermatitis[J]. Allergy Asthma Proc, 2015, 36(5):e81-e85. [20] BRANDT E B, SIVAPRASAD U.Th2 cytokines and atopic dermatitis[J]. J Clin Cell Immunol, 2011, 2(3):1-25. [21] CAMPANA R, DZORO S, MITTERMANN I, et al. Molecular aspects of allergens in atopic dermatitis[J]. Curr Opin Allergy Clin Immunol, 2017, 17(4):269-277. |